Please use this identifier to cite or link to this item:
Title: Oral Serum-Derived Bovine Immunoglobulin/Protein Isolate Has Immunomodulatory Effects on the Colon of Mice that Spontaneously Develop Colitis
Author: Pérez Bosque, Anna
Miró Martí, Ma. Lluïsa
Maijó Ferré, Mònica
Polo Pozo, Francisco Javier
Campbell, Joy M.
Russell, Louis
Crenshaw, Joe D
Weaver, Eric
Moretó, Miquel, 1950-
Keywords: Suplements nutritius
Experimentació animal
Malalties inflamatòries intestinals
Dietary supplements
Animal experimentation
Inflammatory bowel diseases
Issue Date: 3-May-2016
Publisher: Public Library of Science (PLoS)
Abstract: Dietary immunoglobulin concentrates prepared from animal plasma can modulate the immune response of gut-associated lymphoid tissue (GALT). Previous studies have revealed that supplementation with serum-derived bovine immunoglobulin/protein isolate (SBI) ameliorates colonic barrier alterations in the mdr1a-/- genetic mouse model of IBD. Here, we examine the effects of SBI on mucosal inflammation in mdr1a-/- mice that spontaneously develop colitis. Wild type (WT) mice and mice lacking the mdr1a gene (KO) were fed diets supplemented with either SBI (2% w/w) or milk proteins (Control diet), from day 21 (weaning) until day 56. Leucocytes in mesenteric lymph nodes (MLN) and in lamina propria were determined, as was mucosal cytokine production. Neutrophil recruitment and activation in MLN and lamina propria of KO mice were increased, but were significantly reduced in both by SBI supplementation (p < 0.05). The increased neutrophil recruitment and activation observed in KO mice correlated with increased colon oxidative stress (p < 0.05) and SBI supplementation reduced this variable (p < 0.05). The Tact/Treg lymphocyte ratios in MLN and lamina propria were also increased in KO animals, but SBI prevented these changes (both p < 0.05). In the colon of KO mice, there was an increased production of mucosal proinflammatory cytokines such as IL-2 (2-fold), IL-6 (26-fold) and IL-17 (19-fold), and of chemokines MIP-1β (4.5-fold) and MCP-1 (7.2-fold). These effects were significantly prevented by SBI (p < 0.05). SBI also significantly increased TGF-β secretion in the colon mucosa, suggesting a role of this anti-inflammatory cytokine in the modulation of GALT and the reduction of the severity of the inflammatory response during the onset of colitis.
Note: Reproducció del document publicat a:
It is part of: PLoS One, 2016, vol. 11, num. 5, p.
Related resource:
ISSN: 1932-6203
Appears in Collections:Articles publicats en revistes (Bioquímica i Fisiologia)

Files in This Item:
File Description SizeFormat 
664731.pdf3.76 MBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons